TGTX icon

TG Therapeutics

254 hedge funds and large institutions have $1.67B invested in TG Therapeutics in 2024 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 92 increasing their positions, 67 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
254
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$49M
Puts
$35.3M
Net Calls
Net Calls Change

Top Buyers

1 +$51.1M
2 +$36.5M
3 +$19.5M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$14.3M
5
Goldman Sachs
Goldman Sachs
New York
+$14.2M

Top Sellers

1 -$54.9M
2 -$36M
3 -$19.6M
4
VPC
Vestal Point Capital
New York
-$16M
5
Renaissance Technologies
Renaissance Technologies
New York
-$9.45M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$2.23M
77
$2.21M
78
$2.02M
79
$1.98M
80
$1.94M
81
$1.88M
82
$1.84M
83
$1.8M
84
$1.78M
85
$1.75M
86
$1.64M
87
$1.63M
88
$1.56M
89
$1.55M
90
$1.52M
91
$1.48M
92
$1.47M
93
$1.46M
94
$1.44M
95
$1.43M
96
$1.34M
97
$1.34M
98
$1.33M
99
$1.3M
100
$1.26M